original ) (raw )Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function
Arndt Weinmann
Cancers, 2021
View PDFchevron_right
Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
Kliment Bozhilov , Hepatoma Research
Hepatoma Research, 2020
View PDFchevron_right
Comparison of Prognostic Scoring Systems for Prediction of Survival in Hepatocellular Carcinoma
Bulent Baban
Journal of Hepatology, 2016
View PDFchevron_right
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
rohan magoon
Clinical cancer research : an official journal of the American Association for Cancer Research, 2014
View PDFchevron_right
A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma
Jiahong Liang
Journal of immunology research, 2018
View PDFchevron_right
Pre‐operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma
London Ooi
Journal of Surgical Oncology, 2018
View PDFchevron_right
Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
jia lin
Medicine, 2017
View PDFchevron_right
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study
Carlo Smirne
Oncotarget, 2016
View PDFchevron_right
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
Ronnie Poon , Nikki Lee
BMC Cancer, 2009
View PDFchevron_right
Number of Nodules but not Size of Hepatocellular Carcinoma Can Predict Refractoriness to Transarterial Chemoembolization and Poor Prognosis
Kazuhiro Katayama
Journal of Clinical Medicine Research, 2018
View PDFchevron_right
Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization
Hongyu Xue
Translational Cancer Research, 2018
View PDFchevron_right
Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study
Hepatoma Research
Hepatoma Research, 2021
View PDFchevron_right
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country
Aleksandar Bogdanovic
Cancer Management and Research
View PDFchevron_right
Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis
Susan Orloff
The American Journal of Surgery, 2008
View PDFchevron_right
NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization
Olivier Monnet
European journal of gastroenterology & hepatology, 2017
View PDFchevron_right
Comparison Between Neutrophil-Lymphocyte Ratio And Systemic Immune-Inflammation Index As Predictors Of One-Year Survival In Patients With Untreated Advanced Hepatocellular Carcinoma
Imelda Loho
2021
View PDFchevron_right
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within milan criteria
Ioanna Parisi
Liver Transplantation, 2014
View PDFchevron_right
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma
John C Allen
Journal of surgical oncology, 2016
View PDFchevron_right
Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
Harika Gozukara Bag
International Journal of Clinical Practice, 2020
View PDFchevron_right
The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis
menglan li
Scientific reports, 2017
View PDFchevron_right
Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma
Hassan Malik
World Journal of Surgery, 2008
View PDFchevron_right
A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients
Yasmin Saad
European journal of gastroenterology & hepatology, 2018
View PDFchevron_right
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Gianpaolo Vidili
Liver Cancer
View PDFchevron_right
Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre
Mo Abdolell
HPB, 2012
View PDFchevron_right
Study of predictive factors of complete response after chemoembolization for unresectable hepatocellular carcinoma in 162 patients
Nada Lahmidani
Clinical & Experimental Hepatology, 2020
View PDFchevron_right
The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers
Kazuyuki Gyoten
PLOS ONE, 2021
View PDFchevron_right
Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: A Western perspective
Fahad Naeem
Journal of Surgical Oncology
View PDFchevron_right
Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma
Juinn Kam
World Journal of Surgery, 2019
View PDFchevron_right
Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis
Xinsen Xu
PLoS ONE, 2014
View PDFchevron_right
Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
Nakarin Inmutto
Asian Pacific Journal of Cancer Prevention, 2022
View PDFchevron_right
Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Grace L Su
Digestive Diseases and Sciences, 2014
View PDFchevron_right
Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma
Sumihisa Honda
Journal of Gastroenterology and Hepatology, 2004
View PDFchevron_right
Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma
Giuseppe Cabibbo
Liver International, 2015
View PDFchevron_right
Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation
Scott W. Cowan
Journal of Gastroenterology and Hepatology, 2012
View PDFchevron_right
Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization with Drug-Eluting Beads
Luciana Kikuchi
Journal of Cancer Therapy, 2015
View PDFchevron_right